Expertise in
4
conditions

Yungan A. Tao

Department Of Head And Neck Surgery, 
Villejuif, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
4
conditions
Department Of Head And Neck Surgery, 
Villejuif, FR 

Overview

Yungan Tao practices practicing medicine in Villejuif, France.

Tao is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Throat Cancer, Laryngeal Cancer, Nasopharyngeal Carcinoma, and Laryngectomy.

They are actively involved in clinical research, co-authoring 126 peer reviewed articles and participating in 4 clinical trials.

Locations

Department Of Head And Neck Surgery, Villejuif, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Randomized Trial of Loco-regional Radiotherapy Added to Pembrolizumab Alone or With Chemotherapy Versus Systemic Treatment Alone for Patients With Newly Diagnosed Head and Neck Squamous Cell Carcinoma With Synchronous Metastases
Randomized Trial of Loco-regional Radiotherapy Added to Pembrolizumab Alone or With Chemotherapy Versus Systemic Treatment Alone for Patients With Newly Diagnosed Head and Neck Squamous Cell Carcinoma With Synchronous Metastases
Enrollment Status: Recruiting
Publish Date: July 31, 2026
Intervention Type: Drug, Radiation
Study Drugs: Pembrolizumab, Chemotherapy
Study Phase: Phase 3
Phase III Randomized Study With Cisplatinum and Conventional or Adaptive High Dose Radiotherapy for Advanced Head and Neck Cancer
Phase III Randomized Study With Cisplatinum and Conventional or Adaptive High Dose Radiotherapy for Advanced Head and Neck Cancer
Enrollment Status: Completed
Publish Date: January 29, 2025
Intervention Type: Drug, Radiation
Study Phase: Phase 3
Non Inferiority Randomized Trial of Standard Radiotherapy Versus Hypofractionated Split Course Radiotherapy in Elderly Vulnerable Patients With Inoperable Head and Neck Squamous Cell Carcinoma
Non Inferiority Randomized Trial of Standard Radiotherapy Versus Hypofractionated Split Course Radiotherapy in Elderly Vulnerable Patients With Inoperable Head and Neck Squamous Cell Carcinoma
Enrollment Status: Completed
Publish Date: September 22, 2023
Intervention Type: Radiation
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-controlled Phase III Study, to Evaluate the Efficacy of Afatinib (BIBW2992) in Maintenance Therapy After Post- Operative Radio-chemotherapy in Squamous-cell Carcinoma of the Head and Neck: GORTEC 2010-02
A Randomized, Double-blind, Placebo-controlled Phase III Study, to Evaluate the Efficacy of Afatinib (BIBW2992) in Maintenance Therapy After Post- Operative Radio-chemotherapy in Squamous-cell Carcinoma of the Head and Neck: GORTEC 2010-02
Enrollment Status: Completed
Publish Date: June 01, 2021
Intervention Type: Drug
Study Drug: Afatinib
Study Phase: Phase 3
View 3 Less Clinical Trials

126 Total Publications

Postoperative nivolumab in high-risk head and neck cancer - Authors' reply.
Postoperative nivolumab in high-risk head and neck cancer - Authors' reply.
Journal: Lancet (London, England)
Published: July 16, 2026

Frequently Asked Questions about Yungan A. Tao

Is Yungan A. Tao a top-rated expert for Head and Neck Squamous Cell Carcinoma (HNSCC)?

MediFind is an objective health platform that identifies experts based on real-world data. Yungan A. Tao is classified as an Distinguished expert for Head and Neck Squamous Cell Carcinoma (HNSCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Yungan A. Tao participate in research or clinical trials?

Yes. Yungan A. Tao has published 126 articles and abstracts on conditions like Head and Neck Squamous Cell Carcinoma (HNSCC). You can view a list of Yungan A. Tao's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Tao's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile